ClinCalc Pro
Menu
ALK/ROS1 tyrosine-kinase inhibitor

Crizotinib (Specialist drug)

Brand names: Xalkori

Adult dose

Dose: Specialist initiation only — refer to BNF/SmPC
Route: PO
Frequency: BD

Clinical pearls

  • ALK- or ROS1-positive NSCLC; specialist oncology only

Contraindications

  • See SmPC

Side effects

  • Visual disturbance
  • GI toxicity
  • Hepatotoxicity
  • QT prolongation
  • ILD
  • Bradycardia

Interactions

  • Strong CYP3A4 inhibitors/inducers
  • QT-prolonging drugs

Monitoring

  • LFTs
  • ECG
  • Visual exam

Reference: BNF; https://bnf.nice.org.uk/drugs/crizotinib-specialist-drug/. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.